Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Delsys to develop oral formulations of Parke-Davis drugs

May 4, 1998

Progenitor receives patent protection for stem cell technology

May 4, 1998

NeoRx receives SBIR grant for development of Pretarget technology

May 4, 1998

Improved gastrointestinal delivery of heparin with SNAC

May 1, 1998

Genetronics begins phase II trial of electroporation therapy in U.S.

May 1, 1998

CV Technologies reveals ChemBioPrint technology

April 29, 1998

Xoma licenses protein production technology to Invitrogen for research use

April 29, 1998

Abgenix, Genentech form research collaboration

April 29, 1998

Theratechnologies and Genetix enter strategic alliance

April 28, 1998

Genometrix and GeneMedicine embark on high-throughput screening effort

April 27, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...